Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-26T08:33:48.829Z Has data issue: false hasContentIssue false
  • English
  • Français

Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths

Published online by Cambridge University Press:  01 January 2021

Brandon del Pozo ,
Lawrence S. Krasner  and
Sarah F. George
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns: Health Policy Portal
Information
Journal of Law, Medicine & Ethics , Volume 48 , Issue 2: Opioid Controversies: The Crisis — Causes and Solutions , Summer 2020 , pp. 373 - 375
Copyright
Copyright © American Society of Law, Medicine & Ethics 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wakeman, S.E. and Rich, J.D., “Barriers to Medications for Addiction Treatment: How Stigma Kills,” Substance Use & Misuse 53, no. 2 (2018): 330-333.CrossRefGoogle Scholar
Velander, J.R., “Suboxone: Rationale, Science, Misconceptions,” The Ochsner Journal 18, no. 1 (2018): 23-29.Google Scholar
Doernberg, M., Krawczyk, N., Agus, D., and Fingerhood, M., “Demystifying Buprenorphine Misuse: Has Fear of Diversion Gotten in the Way of Addressing the Opioid crisis?” Substance Abuse 40, no. 2 (2019): 148-153.Google Scholar
Id.Google Scholar
Andraka-Christou, B. and Capone, M.J., “A Qualitative Study Comparing Physician-Reported Barriers to Treating Addiction Using Buprenorphine and Extended-Release Naltrexone in U.S. Office-Based Practices,” International Journal of Drug Policy 54 (2018): 9-17.CrossRefGoogle Scholar
Holtgrave, D.R., “Public Health Errors: Costing Lives, Millions at a Time,” Journal of Public Health Management and Practice 16, no. 3 (2010): 211-215.CrossRefGoogle Scholar
Velander, supra note 2.Google Scholar
Cicero, T.J., Ellis, M.S., and Chilcoat, H.D.,. “Understanding the Use of Diverted Buprenorphine,” Drug and Alcohol Dependence 193 (2018): 117-123.CrossRefGoogle Scholar
Wakeman, supra note 1.Google Scholar
Jickling, K., “Opioid Deaths Rise in Vermont but Plummet in Chittenden County,” Seven Days, February 14, 2019.Google Scholar